Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: West 4Q | Contract Pharma
Breaking News, Financial News

Financial Report: West 4Q

Revenue growth in the quarter was driven by strong Pharmaceutical Systems sales, including sales for H1N1 flu vaccinations, while Tech Group sales were flat at $66.3 million.

West 4Q

4Q Revenues: $293.4 million (+20%)

4Q Earnings: $21.7 million (-15%)

FY Revenues: $1.1 billion (flat)

FY Revenues:
$72.6 million (-15%)

Comments: Revenue growth in the quarter was driven by strong Pharmaceutical Systems sales, including sales for H1N1 flu vaccinations, while Tech Group sales were flat at $66.3 million. Pharmaceutical Systems sales were $229.5 million (+26%) and pharmaceutical components for H1N1 flu vaccination products accounted for $12.3 million of that. The third-quarter acquisition of the drug delivery assets of Plastef Investissements contributed $6.2 million in sales for the quarter. Results in the quarter include $16.3 million, or 6.7%, of favorable foreign exchange.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters